broker's calls

Broker's Calls

DBS reveals 7 stock picks – including ComfortDelGro – for different investing strategies

In its Singapore Equity Picks report dated April 16, the team at DBS Group Research says it has turned “net seller” in the past month to capitalise on the “dividend-driven” rally in March to April

Broker's Calls

DBS downgrades SIA to 'fully valued' as share price runs ahead of fundamentals

DBS Group Research has downgraded Singapore Airlines (SIA) to “fully valued” with a target price of $3.60 that’s based on 0.9 times FY2022 price-to-book (P/BV).

Broker's Calls

OCBC maintains 'hold' on SingPost despite rise in share price on restructuring speculation

OCBC Investment Research analyst Chu Peng is recommending investors continue to “hold” onto Singapore Post (SingPost) with an increased fair value estimate of 74 cents from 71 cents.

DBS starts GHY Culture & Media Holding at 'buy', deems it a 'healthy rising star' - THE EDGE SINGAPORE

Broker's Calls

DBS starts GHY Culture & Media Holding at 'buy', deems it a 'healthy rising star'

DBS Group Research analysts Ling Lee Keng and Chung Wei Le have initiated “buy” on GHY Culture & Media Holding with a target price of $1.

PhillipCapital keeps buoyant outlook on S-REITs, which are expected to resume DPU growth - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital keeps buoyant outlook on S-REITs, which are expected to resume DPU growth

PhillipCapital analyst Natalie Ong has maintained her “overweight” outlook on Singapore REITs (S-REITs) amid catalysts expected from the pick-up in the Singapore economy.

UOBKH downgrades SIA to 'sell' as it is 'less optimistic' of a traffic recovery by 3Q21 - THE EDGE SINGAPORE

Broker's Calls

UOBKH downgrades SIA to 'sell' as it is 'less optimistic' of a traffic recovery by 3Q21

UOB Kay Hian analyst K Ajith has downgraded Singapore Airlines (SIA) to “sell” with a lower target price of $4.40 from $4.43 previously.

CGS-CIMB forecasts record 1Q21 for Jiutian Chemical Group on DMF price uptrend - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB forecasts record 1Q21 for Jiutian Chemical Group on DMF price uptrend

As dimethylformamide (DMF) prices continue on a strong uptrend year-to-date (y-t-d), CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan estimate that Jiutian Chemical Group will post a “rec

Broker's Calls

UOB Kay Hian remains positive on Sunpower Group, touts it as 'year of transformation'

UOB Kay Hian analysts John Cheong and Clement Ho are remaining positive on Sunpower Group following its record PATMI in 2020.

RHB starts 'undervalued' AIMS APAC REIT at 'buy' with highest TP of $1.55 - THE EDGE SINGAPORE

Broker's Calls

RHB starts 'undervalued' AIMS APAC REIT at 'buy' with highest TP of $1.55

RHB Group Research analyst Vijay Natarajan has initiated coverage on AIMS APAC REIT (AA REIT) with a “buy” recommendation and a target price of $1.55, the highest among all the other estimates put

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement

iX Biopharma remains a “buy” for PhillipCapital analyst Tay Wee Kuang, with an unchanged target price of 44.5 cents, as the specialty pharmaceutical company announced that it has entered into a str

×